|
|
|
Panel Prepares Biomeds for Transition to ENFit Connector |
|
|
|
AAMI 2014 conference attendees learned about the magnitude of this transition as a panel of experts covered clinical, technical, regulatory, and logistical details surrounding the change. The FDA’s Scott Colburn, MS, BSN, RN explained ISO and why the design standards for small-bore connectors are so important, while Peggi Guenter, PhD, RN of A.S.P.E.N. detailed changes for enteral connectors, and GEDSA’s Tom Hancock shared the Stay Connected communications initiative. |
|
|
|
Dr. Rory Jaffe of the California Hospital Patient Safety Organization outlined concerns to watch out for during the transition and explained the scope of the California legislation—the state mandate prohibiting the use of an epidural, intravenous, or enteral feeding connector that fits into a connection port other than the type for which it was intended in general acute care, acute psychiatric, and special hospitals. Finally, Purna Prasad, B.E., M.S., Ph.D., CCE from Stanford University Medical Center spoke to attendees about how this transition will affect them back in their hospital setting. |
|
|
|
View the panel’s AAMI presentation |
|
|
|
|
|
Coming in Q4 — The transition to safer connectors begins! |
Introduction of transition sets in the US, Canada, Puerto Rico |
|
Tell your colleagues |
|
|
|
|
|
Did you know? |
|
|
|
|
|
GEDSA is a Collaborating Partner with the Medication Safety Collaborative, an event held earlier this month for multidisciplinary teams of health-system based clinicians and administrators who focus on quality and patient safety. |
|
Learn more |
|
|
|
|
|
Do you have? |
|
|
|
|
|
Raising Awareness: New Enteral Connectors Webinar Recording |
|
If you missed this April 30 webinar by Peggi Guenter, PhD, RN of A.S.P.E.N., the recording is now available. Access the recording for free without CE credit until August 31. (CE credit is available for a fee.) |
|
Listen to the webinar |
|
|
|
|
|
Have you met? |
|
|
|
Mary Logan |
President and CEO |
Association for the Advancement of Medical Instrumentation |
|
In her leadership at AAMI, a nonprofit membership organization whose mission is to support the health care community in the development, management and use of safe and effective medical technology, Mary has been a strong proponent of the initiative for safer connectors. |
|
|
|
|
|
|
|
|
|
Have you told? |
|
|
|
Make sure your biomed staff is ready |
|
Share this email and other Stay Connected tools and information with your technicians and engineers to help smooth the transition to the new ENFit connectors. |
|
Forward this email to your colleagues |
|
|
|
|
|
|
|
|
|
|
|
|
The Stay Connected initiative is organized by the Global Enteral Device Supplier Association (GEDSA) in partnership with leading regulators, associations and other supporting organizations. |
|
|
|
Visit StayConnected2014.org |
|
|
|
If this email was forwarded to you and you would like to sign up to Stay Connected, click here. |
|
|
|
©2014 GEDSA, all rights reserved |
|
|
|
692 N. High St. Suite 207 |
|
|
Columbus, OH 43215 USA |
|
|
|
|
|
|
|
Unsubscribe |
|
|
|
Privacy |
|
|
|
GEDSA is a 501(c)(6) Non-Profit Trade Association incorporated in the State of Ohio, USA, pending federal tax exempt status. GEDSA’s mission is to promote initiatives surrounding safe and optimal delivery of enteral feeding and connectivity. It is GEDSA’s policy and the responsibility of every GEDSA member to comply in all respects with federal, state and international antitrust laws. Any discussion is strictly prohibited for the purpose of raising, lowering, or stabilizing prices; regulating production; allocating markets; encouraging boycotts; fostering unfair trade practices; or assisting monopolization at any GEDSA function. Any questions regarding the meaning or applicability of this policy, as well as any concerns regarding activities or discussions at GEDSA functions, should be promptly brought to the attention of GEDSA’s executive director, officers, and/or legal counsel. |
|
|
|
All material provided in this email is intended for informational purposes only and should not be used to replace regulatory or company-specific documents, nor should it replace the advice of a qualified professional. This information is based on the draft ISO 80369 standard; does not imply or suggest any regulatory clearance of any specific product and may not be predictive of clinical outcomes. Images provided do not imply endorsement of any specific product. All products and product designs are the responsibility of each specific legal manufacturer, distributor or supplier. Products with these design features may be pending regulatory clearance or may not be available in a specific geography. Consult your supplier representative for product-specific availability, indications, contraindications, precautions, and warnings. |
|
|